MADISON, Wis. – July 2, 2001 – Scientists at Third Wave Technologies Inc. (Nasdaq: TWTI) have validated a technological breakthrough with the potential to revolutionize the analysis of gene expression ...
Third Wave Technologies has announced the expansion of its clinical product to include Invader® DNA analyte specific reagents for mutations in the cystic fibrosis (CF) gene. Both the American College ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results